Home > Healthcare > Medical Devices > Therapeutic Devices > Dry Eye Treatment Devices Market

Dry Eye Treatment Devices Market Trends

  • Report ID: GMI6243
  • Published Date: Jul 2023
  • Report Format: PDF

Dry Eye Treatment Devices Market Trends

Increasing prevalence of dry eye disease is anticipated to drive the market growth. Dry eye disease is a common condition that affects a significant number of individuals worldwide. For instance, according to the American Academy of Ophthalmology data, in 2022, around 344 million people worldwide were suffering from dry eye disease and is expected to increase among adult population. Dry eye treatment devices aid in symptoms associated with dry eye disease, such as dryness, burning sensation, redness, itching, as well as restore tear functions among prevalent population thereby augmenting the market growth. Geriatric population are at a higher risk of dry eye syndrome as tear production and quality tend to decline with age, driving the demand for dry eye treatment devices.
 

The widespread use of digital devices, such as smartphones, computers, and tablets, has become an integral part of modern life. Prolonged screen time and decreased blink rate during device use contribute to the development of dry eye symptoms. With the increasing reliance on digital devices across all age groups, the prevalence of dry eye disease is likely to rise, boosting the demand for treatment devices. Additionally, awareness about dry eye disease and its impact on ocular health has been steadily increasing. Individuals are seeking medical attention and diagnosis for their dry eye symptoms, leading to a higher prevalence rate. Improved diagnostic tools and techniques have contributed to better identification and diagnosis of dry eye disease, further driving the demand for treatment devices. The dry eye treatment devices market has witnessed significant advancements in technology, leading to more effective and innovative treatment options.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Market size dry eye treatment devices was worth more than USD 260 million in 2022 and is estimated to reach around USD 586 million by 2032 driven by the high prevalence of dry eye disease coupled with technological advancements in dry eye treatment devices.

The meibomian gland expression (MGX) technology segment held more than 41% share of the dry eye treatment devices industry in 2022 and is set to witness high demand owing to its increasing application to address meibomian gland dysfunction (MGD).

North America market for dry eye treatment devices was valued at USD 95 million in 2022 and is expected to grow substantially through 2032 attributed to the presence of significant industry players, an increase in the number of patients suffering from dry eye disease diseases, and an expanding elderly population.

Some of the major enterprises operating in the dry eye treatment devices business are Alcon, Allergan (AbbVie), BioTissue, Inc, BlephEx LLC, ESW Vision, EyePrint Prosthetics, LLC, Holbar Medical Products, Johnson & Johnson Vision, Lumenis, Mibo Medical Group, NuSight Medical, Sight Sciences among others.

Dry Eye Treatment Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 195
  • Countries covered: 30
  • Pages: 130
 Download Free Sample